...服务平台 on ST elevation acute coronary syndromes，NSTE—ACS）患者经皮冠状动脉介入（percutaneous coronary intervention，PCI）治疗时，不同时机应用血小板膜糖蛋白Hb／IIIa受体拈抗剂盐酸替罗非班的有效性和安全性。
基于4个网页-相关网页
目的评估老年多支冠状动脉病变患者经皮冠状动脉介入治疗(pci)的疗效和安全性。
Objective To evaluate the effectiveness and safety of percutaneous coronary interventional (PCI) therapy in elderly patients with multi-vessel coronary disease.
目的探讨65岁以上急性冠脉综合征(ACS)患者经皮冠状动脉介入治疗(pci)的临床疗效。
Objectives To explore the clinical effects of percutaneous coronary interventions (PCI) on elderly patients with acute coronary syndrome (ACS) who were all more than 65 years old.
目的：评价心肌梗死并左心功能不全患者经皮冠状动脉介入(PCI)治疗对左心收缩功能和左心室重构的影响。
AIM: To assess the effect of percutaneous coronary intervention (PCI) on the cardiac contractive function and remodeling of the left ventricle of myocardial infarction patients over a 3-month period.
应用推荐